article · Tropical Journal of Phytochemistry and Pharmaceutical Sciences
The exploration of medicinal plants as potential alternative therapeutic model comes from the quality content of its chemical compounds that exacerbate remarkable activity, nevertheless, there is the need for further exploit. This study investigated the in vitro antioxidant and antidiabetic potential of the fraction (HEX-ETACF or CF 2) of hexane leaf extract of Tapinanthus bangwensis, but importantly analyzed the likely chemical compounds present in the sample. The study used GC-MS (gas chromatography-mass spectroscopy) machine and spectrophotometer to elucidate the possible compounds and estimate the antioxidant and antidiabetic property respectively. The fraction had significant amount of alkaloids content, while phenolics content appeared higher than the flavonoids content The antioxidant results had the activity of lipid peroxy, 2,2-diphenyl-1-hydrazyl and nitrite radicals significantly inhibited compared to the ferric radicals. Furthermore, the result showed that the fraction inhibited α-amylase's metabolic activity higher than α-glucosidase. The Fourier transition infrared (FTIR) chromatogram had ten peaks, indicated the fraction contains complex molecules that bears carbonyl, methyl, carboxyl and aromatic groups respectively. The GC-MS chromatogram revealed twenty-one peaks, such that butyl-9-octadecenoic acid (8.01%) and nonahexacontanoic acid (0.05%) had the highest and lowest percentage areas (% area). Another GC-MS chromatogram had twenty-seven peaks, with squalene (peak 23; 37.29%) and 1,2-benzenedicarboxylic acid, buty-2-ethylhexyl ester (peak 27; 19.87%) been significantly abundant, suggested the fraction was rich in phenolics and phthalates. Our findings revealed that the compounds demonstrate beneficial effects as antioxidant and antidiabetic agents.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.26538/tjpps/v3i1.5
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.